Stent Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product Type (Drug-Eluting Stent, Bare Metal Coronary Stent, and Bioabsorbable Stent), By Biomaterial (Metallic Biomaterial, Polymeric Biomaterial, and Natural Biomaterial), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others), By Region and Competition
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationStent Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product Type (Drug-Eluting Stent, Bare Metal Coronary Stent, and Bioabsorbable Stent), By Biomaterial (Metallic Biomaterial, Polymeric Biomaterial, and Natural Biomaterial), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others), By Region and Competition
| Forecast Period | 2024-2028 |
| Market Size (2022) | USD 10.06 Billion |
| CAGR (2023-2028) | 6.46% |
| Fastest Growing Segment | Hospitals & Clinics |
| Largest Market | North America |
Market Overview
Key Market Drivers
Increasing Prevalence of Chronic Diseases
Increasing Geriatric Population
Technological Advancements in Stent Development
Increasing Demand for Surgical Procedures
Key Market Challenges
Unfavorable Government Regulations
High Product Recalls
Key Market Trends
Non-Invasive Procedures Options
Unhealthy Lifestyle and Sedentary Habits
Segmental Insights
Biomaterial Insights
Based on the biomaterial, the market is segmented into metallic biomaterial, polymeric biomaterial, and natural biomaterial. In 2022, the Metallic Biomaterial segment has emerged as the dominant force in the market. With a sharp focus on the production of stents for cardiovascular diseases, manufacturers in this industry are proactively increasing their efforts. The utilization of these metallic stents is projected to witness a notable surge alongside the rise in endoscopy and fluoroscopy cases.
Furthermore, the growth trajectory of the polymeric bio-materials segment is also anticipated to gain momentum in the upcoming years. The demand for polymeric stents has witnessed a significant upswing, largely driven by the escalating cases of cardiovascular diseases. Moreover, the government's increasing approval of this type of stent further bolsters market prospects, indicating a promising future for this segment.
End User Insights
Based on the end user, the segment of the hospital has emerged as the largest segment as most of the procedures are carried out within a hospital setup. A hospital setup provides a wide range of facilities to both patients and medical staff, creating a conducive environment for carrying out surgical procedures. With state-of-the-art equipment and a dedicated team of healthcare professionals, hospitals ensure the highest level of care and safety during these procedures.
Furthermore, it is extremely essential to closely monitor the other vital parameters of the patient throughout the procedure, which can be efficiently done within a well-equipped hospital setup. This constant monitoring helps in detecting any potential complications or deviations, allowing for timely intervention and ensuring the best possible outcomes for the patients. In addition to hospitals, the ambulatory surgical center segment is also expected to witness significant growth. These centers offer specialized surgical services on an outpatient basis, providing convenience and cost-effectiveness to patients. With advancements in medical technology and increasing demand for minimally invasive procedures, ambulatory surgical centers are becoming an integral part of the healthcare landscape.
Overall, the availability of multiple facilities within hospitals and the rise of ambulatory surgical centers contribute to the growth and expansion of surgical treatments, ensuring that patients receive the highest quality care in a suitable healthcare setting.
Regional Insights
Recent Developments
- May 2022Medtronic obtained USFDA approval for the Onyx Frontier drug-eluting stent (DES).
- April 2022Translumina, aproducer and manufacturer of cardiovascular medical devices used in interventionalcardiology, launched VIVO ISAR, its dual drug polymer-free coated stent (DDCS),in various international markets, including Europe.
- December 2020MicroportScientific received a registration certificate from the National MedicalProducts Administration of China for the Bridge vertebral drug-eluting stent.The certificate featured a unique drug delivery design that enables faster endothelialization.
Key Market Players
- Medtronic plc
- B. Braun Melsungen AG
- Terumo Corporation
- STENTYS SA
- MicroPort Scientific Corporation
- Meril Life Sciences Pvt. Ltd
- Translumina GmbH
- Biosensors International GroupLimited
- Boston Scientific Corporation
- BIOTRONIK SE & Co. KG
| By Product Type | By Biomaterial | By End User | By Region | |
|
|
|
|
|
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy